Abstract:Objective To study the application effect of WeChat push in patients with remittent stage of severe depression. Methods A total of 90 patients with severe depression admitted to Department of Psychiatry, Liaocheng Fourth People′s Hospital in Shandong Province from December 2015 to August 2017 were selected as research object, they were divided into the control group and the observation group by random double-blind method, with 45 cases in each group. The control group were treated with conventional therapy, and the observation group regularly promoted WeChat knowledge through WeChat ID on the basis of conventional therapy in the control group. The Hamilton depression scale (HAMD), activity of daily living scale (ADL), Hamilton anxiety scale (HAMA) of the two groups before and after treatment were compared, as well as medication compliance score, recurrence rate of depression and rehospitalization rate of the two groups after treatment were compared. Results Finally, 35 cases were included in the observation group and 39 cases were included in the control group. Before treatment, the HAMD, ADL, HAMA of the two groups were compared, and the differences were not statistically significant (P > 0.05). After treatment, the HAMD, ADL and HAMA scores in the two groups were lower than those before treatment, and the HAMD, ADL and HAMA scores in the observation group were lower than those in the control group, the differences were statistically significant (P < 0.05). The medication compliance score in the observation group was higher than that in the control group, the difference was statistically significant (P < 0.05). After treatment, there was no statistically significant difference in recurrence rate of depression and rehospitalization rate between the two groups (P > 0.05). Conclusion WeChat push can relieve depressive symptoms and anxiety symptoms of patients with major depression, improve medication compliance and activity of daily living of patients.
林正华1 章琳2 王继尧2. 微信推送在重度抑郁症缓解期患者中的应用效果[J]. 中国医药导报, 2019, 16(25): 95-98.
LIN Zhenghua1 ZHANG Lin2 WANG Jiyao2. Application effect of WeChat push in patients with remittent stage of severe depression. 中国医药导报, 2019, 16(25): 95-98.
[1] 李红娟,王璇,徐海婷,等.正念冥想训练联合心理引导治疗对中重度抑郁症患者情绪加工和认知控制的影响[J].国际精神病学杂志,2019,46(3):470-473.
[2] 郭洪林,张月良,杨晓琴,等.西酞普兰联合米氮平对重度抑郁症伴睡眠障碍患者的睡眠质量、生活质量及氧化应激水平的影响[J].国际精神病学杂志,2018,45(5):858-860,874.
[3] 水小芳,陈文宇,吕晓东,等.微信教育模式对癌痛患者家属心理健康的影响[J].中华全科医学,2019,17(8):1363-1367.
[4] 陈志霞.微信群模式在乳腺癌患者经外周静脉穿刺中心静脉置管延续护理中的应用效果[J].临床合理用药杂志,2019,12(18):158-159.
[5] 吐达洪,张晶,陈丽婷,等.应用手机微信技术对中老年高血压患者进行服药依从性及血压管理效果的影响[J].中国医学装备,2019,16(6):114-118.
[6] 王晓华,孟伟康,梁晓慧,等.微信平台的延续护理对老年脑卒中主要照顾者心理及照顾能力的影响[J].河北医药,2019,41(13):2059-2062.
[7] 刘平,于欣,汪向东,等.ICD-10精神与行为障碍分类研究用诊断标准[M].北京:人民卫生出版社,1995:82-84.
[8] Lin CH,Park C,McIntyre RS. Early improvement in HAMD-17 and HAMD-7 scores predict response and remission in depressed patients treated with fluoxetine or electroconvulsive therapy [J]. J Affect Disord,2019,253:154-161.
[9] Mlinac ME,Feng MC. Assessment of Activities of Daily Living,Self-Care,and Independence [J]. Arch Clin Neuropsychol,2016,31(6):506-516.
[10] Zimmerman M,Martin J,Clark H,et al. Measuring anxiety in depressed patients:A comparison of the Hamilton anxiety rating scale and the DSM-5 Anxious Distress Specifier Interview [J]. J Psychiatr Res,2017,93:59-63.
[11] Uchmanowicz B,Jankowska EA,Uchmanowicz I,et al. Self-Reported Medication Adherence Measured With Morisky Medication Adherence Scales and Its Determinants in Hypertensive Patients Aged ≥60 Years:A Systematic Review and Meta-Analysis [J]. Front Pharmacol,2019, 10:168.
[12] Newby JM,Hobbs MJ,Mahoney AEJ,et al. DSM-5 illness anxiety disorder and somatic symptom disorder: Comorbidity,correlates,and overlap with DSM-Ⅳ hypochondriasis [J]. J Psychosom Res,2017,101:31-37.
[13] Muzzatti B,Giovannini L,Romito F,et al. Psychological health in long-term cancer survivorship:an Italian survey on depression and anxiety [J]. Psychol Health Med,2017,22(1):12-18.
[14] Rahim T,Rashid R. Comparison of depression symptoms between primary depression and secondary-to-schizophrenia depression [J]. Int J Psychiatry Clin Pract,2017,21(4):314-317.
[15] Wang F,Wang S,Zong QQ,et al. Prevalence of comorbid major depressive disorder in Type 2 diabetes:a meta-analysis of comparative and epidemiological studies [J]. Diabet Med,2019,36(8):961-969.
[16] Abo Aoun M,P Meek B,Modirrousta M. Cognitive profiles in major depressive disorder: comparing remitters and non-remitters to rTMS treatment [J]. Psychiatry Res,2019,279:55-61.
[17] 李红丽,陈滪珊.微信平台应用于护理管理中的优越性研究[J].中国医药科学,2017,7(19):212-214.
[18] 李星霖,李兵,韦鑫.基于微信平台的“互联网+医疗”模式探索与实践[J/OL].现代医院:1-4[2019-07-24]. http://kns.cnki.net/kcms/detail/44.1534.Z.20190723.1157.016.html.
[19] Xu Jia,Wang Junbin,Wang Xiaoxin,et al. iTest:A novel online testing system based on the WeChat platform [J]. Computer Applications in Engineering Education,2019, 27(4):16.
[20] 李瑾,雷健波.医院微信公众平台服务发展现状及建设对策研究[J].中国卫生信息管理杂志,2019,16(3):293-299.
[21] 覃小慧,佘丽君,冯雪兰,等.探讨互联网平台应用于住院患者健康教育的效果研究[J].中国医药科学,2017,7(14):106-108.
[22] 付美华,萧志亮,钟远惠.基于微信平台的延续性康复护理在精神分裂症患者护理中的应用[J].齐鲁护理杂志,2019,25(13):17-20.